SECCHI, MASSIMILIANO
SECCHI, MASSIMILIANO
Istituto di Genetica Molecolare "Luigi Luca Cavalli Sforza"
Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loops
2024 Secchi, Massimiliano; Garbelli, Anna; Riva, Valentina; Deidda, Graziano; Santonicola, Carolina; Formica, Teresa ; Maria, ; Sabbioneda, Simone; Crespan, Emmanuele; Maga, Giovanni
Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNA
2023 Lodola, C; Secchi, M; Sinigiani, V; De Palma, A; Rossi, R; Perico, D; Mauri, Pl; Maga, G
CCR5: A receptor at the center stage in infection
2022 Ellwanger, Gh; Secchi, M; Aliberti, J; Vangelista, L
DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
2022 Secchi, M; Lodola, C; Garbelli, A; Bione, S; Maga, G
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2
2022 Halliday, A; Long, Ae; Baum, He; Thomas, Ac; Shelley, Ks; Oliver, E; Gupta, K; Francis, O; Williamson, Mk; Di Bartolo, N; Randell, Mj; Ben-Khoud, Y; Kelland, I; Mortimer, G; Ball, O; Plumptre, C; Chandler, K; Obst, U; Secchi, M; Piemonti, L; Lampasona, V
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity
2022 Cesarini, S; Vicenti, I; Poggialini, F; Secchi, M; Giammarino, F; Varasi, I; Lodola, C; Zazzi, M; Dreassi, E; Maga, G; Botta, L; Saladino, R
Rational Engineering of a Sub-Picomolar HIV-1 Blocker
2022 Secchi, M; Vangelista, L
A public health antibody screening indicates a six-fold higher SARS-CoV-2 exposure rate than reported cases in children
2021 Hippich, M; Holthaus, L; Assfalg, R; Zapardiel Gonzalo, Jm; Kapfelsperger, H; Heigermoser, M; Haupt, F; Ewald, Da; Welzhofer, Tc; Marcus, Ba; Heck, S; Koelln, A; Stock, J; Voss, F; Secchi, M; Piemonti, L; Rosa, K; Protzer, U; Boehmer, M; Achenbach, P; Lampasona, V; Bonifacio, E; Ziegler, Ag
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
2021 Dispinseri, S; Secchi, M; Pirillo, Mf; Tolazzi, M; Borghi, M; Brigatti, C; De Angelis, Ml; Baratella, M; Bazzigaluppi, E; Venturi, G; Sironi, F; Canitano, A; Marzinotto, I; Tresoldi, C; Ciceri, F; Piemonti, L; Negri, D; Cara, A; Lampasona, V; Scarlatti, G
Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia.
2021 Dispinseri, S; Lampasona, V; Secchi, M; Cara, A; Bazzigaluppi, E; Negri, D; Brigatti, C; Pirillo, Mf; Marzinotto, I; Borghi, M; Rovere-Querini, P; Tresoldi, C; Ciceri, F; Scavini, M; Scarlatti, G; Piemonti, L
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study
2020 Lampasona, V; Secchi, M; Scavini, M; Bazzigaluppi, E; Brigatti, C; Marzinotto, I; Davalli, A; Caretto, A; Laurenzi, A; Martinenghi, S; Molinari, C; Vitali, G; Di Filippo, L; Mercalli, A; Melzi, R; Tresoldi, C; Rovere-Querini, P; Landoni, G; Ciceri, F; Bosi, E; Piemonti, L
Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+ -ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis
2020 Lahner, E; Marzinotto, I; Lampasona, V; Dottori, L; Bazzigaluppi, E; Brigatti, C; Secchi, M; Piemonti, L; Conti, L; Pilozzi, E; Davidson, Hw; Wenzlau, Jm; Annibale, B
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain
2020 Secchi, M; Bazzigaluppi, E; Brigatti, C; Marzinotto, I; Tresoldi, C; Rovere-Querini, P; Poli, A; Castagna, A; Scarlatti, G; Zangrillo, A; Ciceri, F; Piemonti, L; Lampasona, V
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
2020 Vangelista, Luca; Secchi, Massimiliano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loops | 1-gen-2024 | Secchi, Massimiliano; Garbelli, Anna; Riva, Valentina; Deidda, Graziano; Santonicola, Carolina; Formica, Teresa ; Maria, ; Sabbioneda, Simone; Crespan, Emmanuele; Maga, Giovanni | |
| Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNA | 1-gen-2023 | Lodola, C; Secchi, M; Sinigiani, V; De Palma, A; Rossi, R; Perico, D; Mauri, Pl; Maga, G | |
| CCR5: A receptor at the center stage in infection | 1-gen-2022 | Ellwanger, Gh; Secchi, M; Aliberti, J; Vangelista, L | |
| DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective | 1-gen-2022 | Secchi, M; Lodola, C; Garbelli, A; Bione, S; Maga, G | |
| Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2 | 1-gen-2022 | Halliday, A; Long, Ae; Baum, He; Thomas, Ac; Shelley, Ks; Oliver, E; Gupta, K; Francis, O; Williamson, Mk; Di Bartolo, N; Randell, Mj; Ben-Khoud, Y; Kelland, I; Mortimer, G; Ball, O; Plumptre, C; Chandler, K; Obst, U; Secchi, M; Piemonti, L; Lampasona, V | |
| Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity | 1-gen-2022 | Cesarini, S; Vicenti, I; Poggialini, F; Secchi, M; Giammarino, F; Varasi, I; Lodola, C; Zazzi, M; Dreassi, E; Maga, G; Botta, L; Saladino, R | |
| Rational Engineering of a Sub-Picomolar HIV-1 Blocker | 1-gen-2022 | Secchi, M; Vangelista, L | |
| A public health antibody screening indicates a six-fold higher SARS-CoV-2 exposure rate than reported cases in children | 1-gen-2021 | Hippich, M; Holthaus, L; Assfalg, R; Zapardiel Gonzalo, Jm; Kapfelsperger, H; Heigermoser, M; Haupt, F; Ewald, Da; Welzhofer, Tc; Marcus, Ba; Heck, S; Koelln, A; Stock, J; Voss, F; Secchi, M; Piemonti, L; Rosa, K; Protzer, U; Boehmer, M; Achenbach, P; Lampasona, V; Bonifacio, E; Ziegler, Ag | |
| Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival | 1-gen-2021 | Dispinseri, S; Secchi, M; Pirillo, Mf; Tolazzi, M; Borghi, M; Brigatti, C; De Angelis, Ml; Baratella, M; Bazzigaluppi, E; Venturi, G; Sironi, F; Canitano, A; Marzinotto, I; Tresoldi, C; Ciceri, F; Piemonti, L; Negri, D; Cara, A; Lampasona, V; Scarlatti, G | |
| Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia. | 1-gen-2021 | Dispinseri, S; Lampasona, V; Secchi, M; Cara, A; Bazzigaluppi, E; Negri, D; Brigatti, C; Pirillo, Mf; Marzinotto, I; Borghi, M; Rovere-Querini, P; Tresoldi, C; Ciceri, F; Scavini, M; Scarlatti, G; Piemonti, L | |
| Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study | 1-gen-2020 | Lampasona, V; Secchi, M; Scavini, M; Bazzigaluppi, E; Brigatti, C; Marzinotto, I; Davalli, A; Caretto, A; Laurenzi, A; Martinenghi, S; Molinari, C; Vitali, G; Di Filippo, L; Mercalli, A; Melzi, R; Tresoldi, C; Rovere-Querini, P; Landoni, G; Ciceri, F; Bosi, E; Piemonti, L | |
| Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+ -ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis | 1-gen-2020 | Lahner, E; Marzinotto, I; Lampasona, V; Dottori, L; Bazzigaluppi, E; Brigatti, C; Secchi, M; Piemonti, L; Conti, L; Pilozzi, E; Davidson, Hw; Wenzlau, Jm; Annibale, B | |
| COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain | 1-gen-2020 | Secchi, M; Bazzigaluppi, E; Brigatti, C; Marzinotto, I; Tresoldi, C; Rovere-Querini, P; Poli, A; Castagna, A; Scarlatti, G; Zangrillo, A; Ciceri, F; Piemonti, L; Lampasona, V | |
| Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses | 1-gen-2020 | Vangelista, Luca; Secchi, Massimiliano |